PremiumCompany AnnouncementsAstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market2d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors2d agoAZN
PremiumCompany AnnouncementsAstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections3d agoAZN
PremiumCompany AnnouncementsAstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan3d agoAZN